HIV, first human experiment to eradicate the virus with genetic editing

The new gene therapy for HIV that has just been approved by the Federal Drug Administration for the start of phase 1 and 2 human trials, with the hope of achieving complete eradication of the virus from cells, is partly Italian of infected patients. In the preclinical experimentation it was seen that the drug, EBT-101, developed by Kamel Khalili of Temple University and by the group of prof.